LIMAF(LIMAF)
LIMAF
No analyst ratings available
No analyst price targets available for LIMAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $11.67B | $12.11B |
| Low | $11.49B | $11.81B |
| High | $11.98B | $12.42B |
| EBITDA Avg | $1.59B | $1.65B |
| Low | $1.56B | $1.61B |
| High | $1.63B | $1.69B |
| EBIT Avg | $903M | $938M |
| Low | $889M | $915M |
| High | $928M | $962M |
| Net Income Avg | $714M | $795M |
| Low | $695M | $774M |
| High | $739M | $823M |
| EPS Avg | $11.92 | $13.27 |
| Low | $11.61 | $12.92 |
| High | $12.33 | $13.73 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.96B | $2.76B | $3.11B | $3.38B | $3.10B | $2.76B |
| Low | $2.91B | $2.72B | $3.06B | $3.32B | $3.05B | $2.72B |
| High | $3.02B | $2.82B | $3.17B | $3.45B | $3.17B | $2.82B |
| EBITDA Avg | $402M | $375M | $423M | $459M | $422M | $376M |
| Low | $396M | $369M | $416M | $452M | $415M | $370M |
| High | $411M | $383M | $432M | $469M | $431M | $384M |
| EBIT Avg | $229M | $214M | $241M | $261M | $240M | $214M |
| Low | $225M | $210M | $237M | $257M | $236M | $210M |
| High | $234M | $218M | $246M | $267M | $245M | $218M |
| Net Income Avg | $175M | $155M | $214M | $224M | $194M | $176M |
| Low | $172M | $152M | $210M | $219M | $190M | $173M |
| High | $180M | $159M | $220M | $230M | $200M | $181M |
| EPS Avg | $2.94 | $2.60 | $3.59 | $3.75 | $3.25 | $2.95 |
| Low | $2.88 | $2.55 | $3.52 | $3.67 | $3.19 | $2.89 |
| High | $3.02 | $2.67 | $3.69 | $3.85 | $3.35 | $3.04 |
| Analysts (Rev / EPS) | 4 / 1 | 3 / 2 | 3 / 2 | 2 / 1 | 2 / 1 | 3 / 2 |